PCV13: Effective Against First-Episode CAP in Older Adults
The 13-valent pneumococcal conjugate vaccine reduced nearly by half vaccine-type community acquired pneumonia in adults aged 65 years and older.
8 ICD-10 Areas for Pediatricians to Watch
Research shows that pediatricians are at higher risk than other physician groups for financial loss as they transition to ICD-10. Here, 8 areas you can focus on now.
Hospitalization for Pneumonia Linked to Risk for CVD
Risk of MI, stroke, and fatal coronary heart disease remained elevated among some patients hospitalized for pneumonia up to 10 years after the index event.
Record Spending and Other Top Medical News
Get highlights in 6 slides of headlines that made news this week: billions spent on medicine; patient myths about opioids; heart and lung health; transparency in research.
The 3 Scourges of Infectious Disease
Tuberculosis, measles, and influenza have declined over the years but not gone away. See the slides that follow for key facts and figures on the current state of these ongoing public health threats.
6 Top Primary Care Items From Around the Web
A look around the web at breaking news -- not all of it medical.
Asthma and the Metabolic Syndrome: A Look at the Links
Asthma and the metabolic syndrome may be more closely related than once believed. A short slide show summarizes key studies of known connections.
3 Things About a Man’s Health You Should Know
A nasal spray may help men cut calories, a tango-a-day can help keep CVD away, and taking up Spanish or guitar may help a guy remember his anniversary date.
Triptans and Ergotamines: What’s the CV Risk?
Triptan and ergotamine drugs are staples of acute migraine treatment. But questions about their cardiovascular safety linger in the absence of clear evidence. A short slide show looks at what we do know.
Weight Loss Improves Atrial Fibrillation, Cardiometabolic Profile
Results of the LEGACY study show long-term weight loss decreases AF burden and supports sustained sinus rhythm. A short slide show summarizes the 2015 ACC late-breaking abstract.
Testosterone: Terrible or Terrific?
The answer might depend on which study group you ask-and when. Facts from 3 new analyses of testosterone in action are presented in the 7 slides that follow.
Make the Right Inhaler Choice for Pediatric Asthma Patients
Making a good match between a young patient and an inhaler device is a first step toward optimal asthma management. Find a brief review of how to make that match in this short slide show.
WHO and How Much Sugar?
Evidence-based recommendations on the intake of free sugars to reduce the risk of noncommunicable diseases are the ingredients of a new WHO guideline. Find the recipe in these slides.
A Neurologist on a Medical Mission
Health expectations and standards of safety in this part of the world are clearly different from what most of us are used to. But it is my impression that “laying on of hands” offers encouragement and hope.
Atrial Fibrillation: More Than an Electrical Problem
A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).
5 Things About Migraine That Really Hurt
Better understanding of migraine causes and related issues could result in enhanced patient care and prevention, but clinicians face some serious challenges-here are 5.
6 Things That Might Persuade Parents to Vaccinate
When parents play out worst case scenarios in protest against routine vaccination, maybe one or two of these 6 options for response will come in handy.
11 New FDA-Approved Primary Care Drugs
In the past few months, the FDA has approved a number of drugs for a variety of primary care disorders. Here’s a look at 11 of the newest.
Pediatric Asthma Refresher for the Primary Care Clinician
In the United States asthma affects nearly 7 million children. Brush up on the core components of pediatric asthma care with this short slide show.
Game Change in the World of Atrial Fibrillation
The absence of an antidote may soon disappear as a reason to avoid prescribing a novel oral anticoagulant to patients with atrial fibrillation, based on promising phase III trial results.